{"id":"W2770192733","doi":"10.1016/j.atherosclerosis.2017.11.014","title":"Reply to: “PCSK9 antagonists and inflammation”","year":2017,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"PCSK9; Inflammation; Alirocumab; Medicine; Canakinumab; Internal medicine; Cholesterol; Endocrinology; LDL receptor; Apolipoprotein B; Lipoprotein; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004527757,0.0003448449,0.0007699907,0.0001143,0.0003149737,0.0001744229,0.0002045026,0.0005667565,0.00007257319],"category_scores_gemma":[0.0001607797,0.0002959927,0.00031285,0.00007191718,0.00009793103,0.00008372028,0.0001314025,0.0009138185,0.0002266146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00010971,"about_ca_system_score_gemma":0.0001589829,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009842387,"about_ca_topic_score_gemma":0.000008585552,"domain_scores_codex":[0.9978594,0.00006844896,0.0003435822,0.0006446422,0.0006412482,0.0004427404],"domain_scores_gemma":[0.9975079,0.00003205052,0.0002032864,0.001914454,0.0001316116,0.0002106697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001725948,0.0000103334,0.001063062,0.0005188035,0.0002402143,0.00009788244,0.0001818735,1.09724e-7,0.0007634854,0.000008842388,0.9693481,0.02775009],"study_design_scores_gemma":[0.000685713,0.0001836846,0.02328052,0.0006098932,0.0002377712,0.00009935672,0.000007303189,0.000002175879,0.0009558602,0.00003052163,0.9736159,0.0002912954],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.03520478,0.0005038874,0.00006705156,0.9596318,0.000488955,0.001337714,0.00006049075,0.0001345604,0.002570781],"genre_scores_gemma":[0.01064986,0.0006295936,0.001650105,0.9643282,0.01137981,0.0002394983,0.0002490803,0.0001726116,0.01070119],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.02745879,"threshold_uncertainty_score":0.9999492,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02662811122925662,"score_gpt":0.2715917686241107,"score_spread":0.244963657394854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}